Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-08-10

Clinical Trial Update: Efficacy of Tadalafil/Solifenacin VS Tamsulosin/Solifenacin Combination Therapy for BPH/OAB [Phase 4]

View source ↗

Summary

Phase 4 trial comparing tadalafil/solifenacin vs tamsulosin/solifenacin for BPH with concomitant overactive bladder; current status unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Solifenacin (solifenacin)
  • TADALAFIL (TADALAFIL)
  • Tamsulosin (tamsulosin)

Snippet

Sponsor: Mansoura University | Conditions: Benign Prostatic Hyperplasia, Overactive Bladder | Phase 4 | Status: UNKNOWN